Third Harmonic Bio Inc (THRD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access THRD Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Third Harmonic Bio Inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent271.61
Cash & Short-term Investments271.00
Prepaid Expense And Other Assets Current4.39
Total Current Assets276.00
Equipment/Property/Plant Net0.12
Other Assets, Noncurrent2.00
Restricted Cash Noncurrent0.46
Operating Lease Right Of Use Asset2.85
Total Assets279.84
Liabilities
Accounts Payable, Current AC2.68
Other Liabilities, Current2.42
Total Current Liabilities5.10
Total Long-term Debt0.00
Other liabilities, Noncurrent2.11
OperatingLeaseLiabilityNoncurrent2.11
Accrued Expense And Other Current Liabilities1.53
Total Liabilities7.22
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock448.14
Retained Earnings / Accumulated Deficit-175.52
Other Equity0.00
Common Stockholder's Equity272.62
Total Stockholder's Equity272.62
Liabilities & Stockholder's Equity279.84
4 historic quarters locked

Sign in to unlock the full Third Harmonic Bio Inc balance sheet history.

About Third Harmonic Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-066412

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.